Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Vaxxinity logo — Our mission is to democratize health by pioneering the third...

Vaxxinity

Our mission is to democratize health by pioneering the third biologic revolution

Founded 2019 United States United States 44 employees Grant Total: $9.25M Biotechnology, Pharmaceutical

General Information

Company Name Vaxxinity
Founded Year 2019
Location United States United States +1
Founders / Decision Makers
Team member
Employees 44
Industries Biotechnology, Pharmaceutical
Funding Stage Grant
Social

Get notified when Vaxxinity moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vaxxinity

Vaxxinity is a U.S.-based global biotechnology company that is pioneering a new class of medicines with the mission to democratize health. The company is headquartered in Dallas, TX and has operations in the United States, Latin America, Europe, and Asia. Vaxxinity's proprietary technology platform focuses on the innovation of synthetic peptide vaccines for both infectious diseases such as COVID-19, as well as chronic diseases including Alzheimer's, Parkinson’s, migraine, and hypercholesterolemia. The company's optimized pipeline aims to achieve a potentially historic global impact on human health. The key to Vaxxinity's platform lies in the proprietary library of UBITh peptides, which are immunosilent and can elicit highly specific antibodies when linked to custom-designed target antigens. The company was founded in 2019 and operates within the biotechnology and pharmaceutical industries. Their last investment of $9.25 million was a grant investment received on April 7, 2022 from the Coalition for Epidemic Preparedness Innovations. This significant investment underscores the recognition of Vaxxinity's potential to make a substantial impact on global healthcare.

Taxonomy: vaccines, chronic diseases, infectious diseases, synthetic peptide vaccines, Alzheimer's, Parkinson's, migraine, hypercholesterolemia, UBITh peptides, immunosilent technology, clinical stage biotechnology, global impact, proprietary technology platform

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
07 Apr 2022
Seed Round •••••• 1
Investor
22 Apr 2020

Vaxxinity Alternatives & Competitors

Vaxxinity vs
mCureX Therapeutics, Inc.
mCureX Therapeutics, Inc. Korea South

Pharmaceuticals, focuses on the research and development of mRNA (messenger RNA) vaccines and therap...

6 employees
Health Care, Health and Wellness
Compare Vaxxinity vs mCureX Therapeutics, Inc.
Vaxxinity vs
ECO Animal Health
ECO Animal Health

We specialise in the development and marketing of high quality products for the control of disease i...

96 employees
Vaxxinity vs
United Biomedical, Inc. (UBI)
United Biomedical, Inc. (UBI) United States

Pioneering the future of healthcare with innovative immunotherapeutics and vaccines for chronic and...

44 employees
Biotechnology, Health Care
Compare Vaxxinity vs United Biomedical, Inc. (UBI)
Also compare with: Vaxxinity vs Immunomic Therapeutics, Inc. Immunomic Therapeutics, Inc.

FAQ About Vaxxinity

Our mission is to democratize health by pioneering the third biologic revolution
Vaxxinity was founded in 2019.
Vaxxinity is headquartered in United States.
Vaxxinity operates in the following industries: Biotechnology, Pharmaceutical.
Vaxxinity has approximately 44 employees.
Vaxxinity has completed 2 funding rounds, raising a total of $9.25M. The latest funding stage is Grant.
Top alternatives and competitors to Vaxxinity include mCureX Therapeutics, Inc., ECO Animal Health, United Biomedical, Inc. (UBI), Immunomic Therapeutics, Inc., IMMORNA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vaxxinity and mCureX Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vaxxinity and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy